Brief: Alembic Pharmaceuticals Gets USFDA Final Approval For Icatibant Injection 30 MG/3ML Single Dose Prefilled Syringe
17/06/2024 07:48
June 17 (Reuters) - Alembic Pharmaceuticals Ltd
ALEM.NS :
* ALEMBIC PHARMACEUTICALS - GETS USFDA FINAL APPROVAL FOR
ICATIBANT INJECTION 30 MG/3ML SINGLE DOSE PREFILLED SYRINGE
Source text for Eikon: ID:nBSE5by15k
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand